Back to search

Article

Clinicopathological and prognostic correlations of plasma biomarkers in neurodegenerative diseases

2025-12-08

Abstract excerpt

Plasma biomarkers have emerged as powerful tools to identify Alzheimer’s disease (AD) pathology and are increasingly used for diagnosis and monitoring. However, their wider differential diagnostic and prognostic value in neurodegenerative diseases other than AD remains unclear. This study tested and compared the diagnostic and prognostic performance of neurofilament light chain (NfL), p-tau217, Aβ42/40 and GFAP, i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
802df37f-58c7-5c3d-b222-4ba816a0c1e5
DOI
10.64898/2025.12.07.25341788
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinicopathological and prognostic correlations of plasma biomarkers in neurodegenerative diseasesDOI 10.64898/2025.12.07.25341788
Performance of plasma p‐tau217 and NfL in an unselected memory clinic settingSemantic proximity
Plasma Biomarkers in the Distinction of Alzheimer’s Disease and Frontotemporal DementiaSemantic proximity
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort.Semantic proximity
Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinicsSemantic proximity
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohortSemantic proximity
Performance of Plasma Amyloid β, Total Tau and Neurofilament Light Chain Levels for Alzheimer’s Disease IdentificationSemantic proximity
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.Semantic proximity
Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity
The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementiaSemantic proximity
A plasma biomarker panel for detecting early amyloid-β accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer’s diseaseSemantic proximity
Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease StagesSemantic proximity
Plasma and CSF proteomic signatures related to Alzheimer’s, α-synuclein, or vascular pathologies and clinical declineSemantic proximity
Select a neighboring publication to make it the new centre.